IMMUNOGEN

Serial Number 97097296
Registration 6774914
700

Registration Progress

Application Filed
Oct 28, 2021
Under Examination
Approved for Publication
Apr 12, 2022
Published for Opposition
Apr 12, 2022
Registered
Jun 28, 2022

Trademark Image

IMMUNOGEN

Basic Information

Serial Number
97097296
Registration Number
6774914
Filing Date
October 28, 2021
Registration Date
June 28, 2022
Published for Opposition
April 12, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 28, 2022
Registration
Registered
Classes
005

Rights Holder

ImmunoGen, Inc.

03
Address
830 Winter Street
Waltham, MA 02451

Ownership History

ImmunoGen, Inc.

Original Applicant
03
Waltham, MA

ImmunoGen, Inc.

Owner at Publication
03
Waltham, MA

ImmunoGen, Inc.

Original Registrant
03
Waltham, MA

Legal Representation

Attorney
Jenevieve Maerker

USPTO Deadlines

Next Deadline
1078 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-06-28)
Due Date
June 28, 2028
Grace Period Ends
December 28, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

9 events
Date Code Type Description Documents
Jun 28, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 28, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 12, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 12, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 23, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 9, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 1, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of cancer; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
First Use Anywhere: Dec 19, 2019
First Use in Commerce: Dec 19, 2019

Additional Information

Pseudo Mark
IMMUNO GEN

Classification

International Classes
005